Keywords
Insulin resistance
Risk factors
Etiology
Diabetes
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Understand the best practices and forms of intervention used in metabolic syndrome to promote the improvement of the quality of life of these patients. Methods: This work is an integrative and descriptive review with a qualitative approach. In relation to the inclusion criteria established for the works, studies that were published, preferably between 2017 and 2022, were chosen and 10 studies were selected. Results: It was possible to observe that the main clinical manifestations are central obesity and insulin insufficiency; The main risks are directly associated with some clinical manifestation, being mainly related to obesity, leading to an increase in cardiovascular diseases and diabetes. Final considerations: The risks and harms are associated with the symptoms presented. As the main symptom of risk, obesity was cited, which leads to several problems in the individual's health, not only metabolic, but also diabetes, cardiovascular diseases, among others, which can cause the person's death. It was found that the most effective treatments for improving the quality of life of individuals suffering from Metabolic Syndrome are a balanced diet and physical exercise.
References
CAMPINA RM, et al. Prevalence and factors associated with metabolic syndrome in vulnerable population in northern Brazil: a cross-sectional study. Journal of Human Growth and Development, 2021; 31(2): 291-301.
COSTA MVG, et al. Risco cardiovascular aumentado e o papel da síndrome metabólica em idosos hipertensos. Escola Anna Nery, 2021; 25(1).
DENSON JL, et al. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients with COVID-19. JAMA Netw Open, 2021; 4(12).
DUTRA HS e CHIACHIO NDF. Prevalência e Fatores de Riscos Associados à Síndrome Metabólica entre os Funcionários Atendidos no Ambulatório do SESI - Serviço Social da Indústria de Vitória da Conquista – BA. Revista Multidisciplinar e de Psicologia, 2020; 14(53): 1102-1115.
FALCÃO GC e ROCHA TES. Percepção dos Profissionais de Saúde Acerca da Síndrome Metabólica. Revista Contexto & Saúde, 2020; 20(38): 177-184.
FÉLIX NDC e NÓBREGA MML. Síndrome metabólica: análise conceitual no contexto da enfermagem. Revista Latino-Americana de Enfermagem, 2019; 27.
GODOY LS e ROMANO LH. Artigo de Revisão: Síndrome Metabólica Insulínica. Revista Saúde em Foco, 2018; 10: 295-9.
ISLAM RU, et al. Persistence of SARS-CoV-2 RNA in a male with metabolic syndrome for 72 days: A case report. SAGE Open Med Case Reports, 2021; 9: 2050313X2198949.
JÚNIOR ACS, et al. Repercussões da prevalencia da síndrome metabólica em adultos e idosos no contexto da atenção primária. Revista de salud pública, 2018; 20(6): 735-740.
JUNQUEIRA CLC, et al. Síndrome Metabólica: o risco cardiovascular é maior que o risco dos seus componentes isoladamente? Revista Brasileira de Cardiologia, 2011; 24(5): 308-15.
KLARIC D, et al. Metabolic syndrome: A case report. Ann Clin Endocrinol Metab., 2021; 5(1): 031-5.
MONTE IP, et al. Comparação entre quatro diferentes critérios de diagnóstico de síndrome metabólica em indivíduos do Arquipélago do Marajó (Pará, Brasil). Revista da Associação Brasileira de Nutrição, 2019; 10(1): 96-102.
NASCIMENTO BMO, et al. Fatores que influenciam na prevalência da síndrome metabólica: revisão literatura. Revista JRG de Estudos Acadêmicos, 2023; 6(13): 406-414.
NETO JCG, et al. Prevalência da síndrome metabólica e de seus componentes em pessoas com diabetes mellitus tipo 2. Texto & Contexto – Enfermagem, 2018; 27(3).
OLIVEIRA LVA, et al. Prevalência da Síndrome Metabólica e seus componentes na população adulta brasileira. Ciência & Saúde Coletiva, 2020; 25(11): 4269-80.
PENALVA DQF. Síndrome metabólica: diagnóstico e tratamento. Revista de Medicina, 2008; 87(4).
RODRIGUES MC, et al. Prevalence and factors associated with metabolic syndrome in vulnerable population in northern Brazil: a cross-sectional study. Journal of Human Growth and Development, 2021; 31(2): 291-301.
SHILOAH R, et al. Reversal of risk for metabolic syndrome in a post-menopausal woman presenting with multiple medical problems using an integrative tratment approach: a case report. Maryl Univ Integr Heal, 2020; 1-12.
SILVA MF, et al. Prevalência da síndrome metabólica: uma revisão de literatura. Scientia Generalis, 2021; 2(2): 298-306.
ULAGANATHAN V, et al. A case-control study of the association between metabolic syndrome and colorectal cancer: A comparison of International Diabetes Federation, National Cholesterol Education Program Adults Treatment Panel III, and World Health Organization definitions. J Gastrointest Oncol., 2018; 9(4): 650-63.
XAVIER IGG. Prevalência de síndrome metabólica em indivíduos com doença de chagas crônica. Dissertação (Mestrado em Pesquisa Clínica em Doenças Infecciosas) - Instituto Nacional de Infectologia Evandro Chagas – INI/Fiocruz, Rio de Janeiro, 2019; 81.
YANG P, et al. Complete androgen insensitivity syndrome in a young woman with metabolic disorder and diabetes: A case report. Med (United States), 2018; 97(33): 4-6.